And dont underappreciate the importance of this process
Pharmacokinetic limitations Esculetin has very low water solubility due to its lipophilic coumarin structure and limited hydrogen bonding with water
Zheng H, Wei J, Wang L, et al
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.
The result is a peptide that retains amylin's biological activity but doesn't form amyloid fibrils
Nordisk Psykiatrisk Tidsskrift, 39(Supplement 11), 4753